Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms.

Abstract

OBJECTIVE To assess the efficacy of Gaviscon Double Action (DA) alginate antacid chewable tablets for reducing esophageal acid exposure in Chinese patients with gastroesophageal reflux disease (GERD). METHODS Altogether 44 patients reporting moderate to severe heartburn symptoms underwent two pH monitoring visits. The treatment sequence was randomized to… (More)
DOI: 10.1111/1751-2980.12406

Topics

Cite this paper

@article{Yuan2016AlginateA, title={Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms.}, author={Yao Yuan and Jing-Yuan Fang and Duo Wu Zou and Nigel Levinson and Bartosz Jenner and Joanne Wilkinson}, journal={Journal of digestive diseases}, year={2016}, volume={17 11}, pages={725-734} }